Citation Impact
Citing Papers
A Prediction Model for Lung Cancer Diagnosis that Integrates Genomic and Clinical Features
2008
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline
2009
Hallmarks of Cancer: The Next Generation
2011 Standout
Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
2015
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
2007
Gene expression profiling predicts clinical outcome of prostate cancer
2004
Thyroid cancer
2016 Standout
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Epithelial-Mesenchymal Transitions in Development and Disease
2009 Standout
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
2007 Standout
Complex patterns of ETS gene alteration arise during cancer development in the human prostate
2007
Serum thyroglobulin and 131I whole body scan after recombinant human TSH stimulation in the follow-up of low-risk patients with differentiated thyroid cancer
2003
Pancreatic cancer
2020 Standout
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
A Single Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Measurement Predicts Differentiated Thyroid Carcinoma Metastases Three to Five Years Later
2005
Does an undetectable rhTSH‐stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
2010
Cancer Metastasis: Building a Framework
2006 Standout
Lung Cancer
2008 Standout
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
Phaeochromocytoma
2005 Standout
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Head and neck cancer
2008 Standout
Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2′,5′-oligoadenylate synthetase from prostate cancer cells
2006
Radiomics: Images Are More than Pictures, They Are Data
2015 Standout
Classification of Surgical Complications
2004 Standout
Treatment of Obesity with Celastrol
2015 Standout
Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Combined with Neck Ultrasonography Has the Highest Sensitivity in Monitoring Differentiated Thyroid Carcinoma
2003
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Dichotomizing continuous predictors in multiple regression: a bad idea
2005 Standout
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
2006
Procedure guideline for radioiodine therapy and 131iodine whole-body scintigraphy in paediatric patients with differentiated thyroid cancer
2007
Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis
2008 Standout
Individual patient data analysis to assess modifications to the RECIST criteria
2008
The landscape of long noncoding RNAs in the human transcriptome
2015 Standout
Preparation for radioactive iodine administration in differentiated thyroid cancer patients
2002
Cancer genes and the pathways they control
2004 Standout
A UBE2O-AMPKα2 Axis that Promotes Tumor Initiation and Progression Offers Opportunities for Therapy
2017
FOXP3 and survival in urinary bladder cancer
2011
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy
2006
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Proposal for definition and severity grading of pancreatic anastomosis failure and pancreatic occlusion failure
2007
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
2008
A module of negative feedback regulators defines growth factor signaling
2007
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Positive Predictive Value of Serum Thyroglobulin Levels, Measured during the First Year of Follow-Up after Thyroid Hormone Withdrawal, in Thyroid Cancer Patients
2003
A simulation study to evaluate the impact of the number of lesions measured on response assessment
2008
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Postoperative pancreatic fistula: An international study group (ISGPF) definition
2005 Standout
The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-β signaling
2009
Quality of Complication Reporting in the Surgical Literature
2002
Neuroblastoma
2007 Standout
Positron emission tomography in thyroid cancer management
2002
Total Laparoscopic Pancreaticoduodenectomy
2010
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
2005
Radiologic Measurements of Tumor Response to Treatment: Practical Approaches and Limitations
2008
Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays
2003
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Clonal evolution in cancer
2012 StandoutNature
Confidence intervals for the effect of a prognostic factor after selection of an ‘optimal’ cutpoint
2004
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L
2011 StandoutNobel
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
RECIST revisited: A review of validation studies on tumour assessment
2006
Molecular portraits and the family tree of cancer
2002
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 Standout
Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
2017 Standout
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
2006
Management of Low-Risk Well-Differentiated Thyroid Cancer Based Only on Thyroglobulin Measurement After Recombinant Human Thyrotropin
2002
Usefulness of Recombinant Human Thyrotropin in the Radiometabolic Treatment of Selected Patients with Thyroid Cancer
2001
Recombinant Human Thyroid Stimulating Hormone–Assisted Radioactive Iodine Remnant Ablation in Thyroid Cancer Patients at Intermediate to High Risk of Recurrence
2012
Clinical Comparison of Whole-Body Radioiodine Scan and Serum Thyroglobulin After Stimulation with Recombinant Human Thyrotropin
2002
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group
2005
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
2008
Undetectable Sensitive Serum Thyroglobulin (<0.1 ng/ml) in 163 Patients with Follicular Cell-Derived Thyroid Cancer: Results of rhTSH Stimulation and Neck Ultrasonography and Long-Term Biochemical and Clinical Follow-Up
2012
Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation?
2002
Serial Therapy-Induced Changes in Tumor Shape in Cervical Cancer and Their Impact on Assessing Tumor Volume and Treatment Response
2006
Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography
2004
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
2018 Standout
PET-based treatment planning in radiotherapy: a new standard?
2007
Measures of Response: RECIST, WHO, and New Alternatives
2006
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
2006 Standout
A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation.
2002
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
A Consensus Report of the Role of Serum Thyroglobulin as a Monitoring Method for Low-Risk Patients with Papillary Thyroid Carcinoma
2003
Monitoring Thyroglobulin in a Sensitive Immunoassay Has Comparable Sensitivity to Recombinant Human TSH-Stimulated Thyroglobulin in Follow-Up of Thyroid Cancer Patients
2006
Gene Expression Alterations in Prostate Cancer Predicting Tumor Aggression and Preceding Development of Malignancy
2004
Gene expression profiling identifies clinically relevant subtypes of prostate cancer
2004
Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression
2004
X-Tile
2004 Standout
Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
2004
Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
2005
Combined Intraperitoneal and Intravenous Chemotherapy for Women With Optimally Debulked Ovarian Cancer: Results From an Intergroup Phase II Trial
2003
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Postoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical Prostatectomy
2005
Ablation of Thyroid Residues with 30 mCi 131I: A Comparison in Thyroid Cancer Patients Prepared with Recombinant Human TSH or Thyroid Hormone Withdrawal
2002
Thyroid carcinoma
2003 Standout
Phase III Trial of Androgen Ablation With or Without Three Cycles of Systemic Chemotherapy for Advanced Prostate Cancer
2008
Works of Alex Smith being referenced
Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy
2005
A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response
2005
A statistical simulation study finds discordance between WHO criteria and RECIST guideline
2004
Prospective Randomized Clinical Trial of the Value of Intraperitoneal Drainage After Pancreatic Resection
2001
Methods for categorizing a prognostic variable in a multivariable setting
2003
Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance
2004
Preparation by Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal Are Comparable for the Detection of Residual Differentiated Thyroid Carcinoma
2001
Response assessment classification in patients with advanced renal cell carcinoma treated on clinical trials
2003
Combined versus sequential chemo-endocrine therapy in advanced prostate cancer: final results of a randomized Southwest Oncology Group study.
1990
Clinical Value of Combined Positron Emission Tomography/Computed Tomography Imaging in the Interpretation of 2-Deoxy-2-[F-18]fluoro-d-glucose–Positron Emission Tomography Studies in Cancer Patients
2005
Intraperitoneal Chemotherapy for Ovarian Carcinoma: Results of Long-Term Follow-Up
2002
Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement.
2003
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease.
2002